The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Open accessAbstract
BACKGROUND: Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies. METHODS: After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved. RESULTS: The revised definitions retain the original classifications of "proven," "probable," and "possible" invasive fungal disease, but the definition of "probable" has been expanded, whereas the scope of the category "possible" has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only. CONCLUSIONS: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The development of standardized diagnostic criteria for invasive aspergillosis has been a major improvement for IPA (94).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [94]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,705
Self-citationAşçıoğlu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Billé, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,315
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802
Self-citationPosaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P. H., Langston, A. A., Tarantolo, S., Greinix, H., de Azevedo, W. M., Reddy, V. S., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,339
Walsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Self-citationWalsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszyńska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 907
Self-citationAustin, J. H. M., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Rémy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Self-citationCornely, O. A., Maertens, J. A., Bresnik, M., Ebrahimi, R., Ullmann, A. J., Bouza, E., Heußel, C. P., Lortholary, O., Rieger, C. T., Boehme, A., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/514341 · Cited by 744
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,024
Alexander, B. D., Smith, P. B., Davis, R. D., Perfect, J. R., & Reller, L. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01183-10 · Cited by 115
Self-citationInvasive fungal disease in autosomal-dominant hyper-IgE syndrome
Vinh, D. C., Sugui, J. A., Hsu, A. P., Freeman, A. F., & Holland, S. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.047 · Cited by 114
Chowdhary, A., Sharma, C., Kathuria, S., Hagen, F., & Meis, J. F. G. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00428 · Cited by 113
Schuster, M. G., Cleveland, A. A., Dubberke, E. R., Kauffman, C. A., Avery, R. K., Husain, S., Paterson, D. L., Silveira, F. P., Chiller, T. M., Benedict, K., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx050 · Cited by 113
Self-citationWinston, D. J., Limaye, A. P., Pelletier, S. J., Safdar, N., Morris, M. I., Meneses, K. G., Busuttil, R. W., & Singh, N. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12963 · Cited by 114
Weigt, S. S., Copeland, C., Derhovanessian, A., Shino, M. Y., Davis, W. A., Snyder, L. D., Gregson, A. L., Saggar, R., Lynch, J. P., Ross, D. J., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12131 · Cited by 113
Gamaletsou, M. N., Walsh, T. J., Zaoutis, T., Pagoni, M., Kotsopoulou, M., Voulgarelis, M., Panayiotidis, P., Vassilakopoulos, T., Angelopoulou, M. K., Marangos, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12312 · Cited by 112
Self-citationNucci, M., Nouér, S. A., Grazziutti, M., Kumar, N. S., Barlogie, B., & Anaissie, E. (2010) · Clinical Infectious Diseases · doi:10.1086/657065 · Cited by 112
White, P. L., Posso, R. B., & Barnes, R. A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00667-15 · Cited by 112
Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
Prattes, J., Valentin, T., Hoenigl, M., Talakić, E., Reisinger, A. C., & Eller, P. (2020) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2020.05.001 · Cited by 112
Serology anno 2021—fungal infections: from invasive to chronic
Lass‐Flörl, C., Samardzic, E., & Knoll, M. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.02.005 · Cited by 112
Hagiwara, D., Takahashi, H., Watanabe, A., Takahashi‐Nakaguchi, A., Kawamoto, S., Kamei, K., & Gonoi, T. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01105-14 · Cited by 111
Corzo-León, D., Satlin, M. J., Soave, R., Shore, T. B., Schuetz, A. N., Jacobs, S. E., & Walsh, T. J. (2015) · Mycoses · doi:10.1111/myc.12318 · Cited by 111
Self-citationAnanda-Rajah, M. R., Grigg, A., Downey, M., Bajel, A. R., Spelman, T., Cheng, A., Thursky, K., Vincent, J., & Slavin, M. A. (2011) · Haematologica · doi:10.3324/haematol.2011.051995 · Cited by 111
Mucormycosis in Iran: a systematic review
Vaezi, A., Moazeni, M., Rahimi, M. T., de Hoog, S., & Badali, H. (2016) · Mycoses · doi:10.1111/myc.12474 · Cited by 111
The Cava Trem Study Group, León, C., Ruiz-Santana, S., Saavedra, P., Castro, C., Loza, A., Zakariya, I., Úbeda, A., Parra, M., Macías, D., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1324-3 · Cited by 110
Heldt, S., Prattes, J., Eigl, S., Spiess, B., Flick, H., Rabensteiner, J., Johnson, G., Prüller, F., Wölfler, A., Niedrist, T., et al. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.05.001 · Cited by 110
Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era
Saliba, F., Delvart, V., Ichaı̈, P., Kassis, N., Botterel, F., Mihaïla-Amrouche, L., Azoulay, D., Adam, R. A., Castaing, D., Bretagne, S., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12129 · Cited by 110
New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis
Rammaert, B., Desjardins, A., & Lortholary, O. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02182.x · Cited by 112
Self-citationHale, K. A., Shaw, P. J., Dalla‐Pozza, L., MacIntyre, C. R., Isaacs, D., & Sorrell, T. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08072.x · Cited by 110
Self-citationMatsumura, Y., Shindo, Y., Iinuma, Y., Yamamoto, M., Shirano, M., Matsushima, A., Nagao, M., Ito, Y., Takakura, S., Hasegawa, Y., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-76 · Cited by 110
Epidemiology of Invasive Mold Infections in Lung Transplant Recipients
Doligalski, C. T., Benedict, K., Cleveland, A. A., Park, B., Derado, G., Pappas, P. G., Baddley, J. W., Zaas, D., Harris, M., & Alexander, B. D. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12691 · Cited by 109
Self-citationLerolle, N., Raffoux, E., Socié, G., Touratier, S., Sauvageon, H., Porcher, R., Bretagne, S., Bergeron, A., Azoulay, É., Molina, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12688 · Cited by 109
A Prospective, International Cohort Study of Invasive Mold Infections in Children
Wattier, R. L., Dvorak, C. C., Hoffman, J. A., Brozovich, A., Bin-Hussain, I. Z., Groll, A. H., Castagnola, E., Knapp, K. M., Zaoutis, T. E., Gustafsson, B. M., et al. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu074 · Cited by 109
Self-citationHill, J. A., Dalai, S. C., Hong, D. K., Ahmed, A. A., Ho, C., Hollemon, D., Blair, L. M., Maalouf, J., Keane-Candib, J., Stevens‐Ayers, T., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1639 · Cited by 109
Aspergillus-Associated Airway Disease, Inflammation, and the Innate Immune Response
Chotirmall, S. H., Al‐Alawi, M., Mirković, B., Lavelle, G., Logan, P. M., Greene, C. M., & McElvaney, N. G. (2013) · BioMed Research International · doi:10.1155/2013/723129 · Cited by 117
Mielcarek, M. B., Furlong, T., Storer, B. E., Green, M. L., McDonald, G., Carpenter, P. A., Flowers, M. E. D., Storb, R. F., Boeckh, M., & Martin, P. J. (2015) · Haematologica · doi:10.3324/haematol.2014.118471 · Cited by 109
Neofytos, D., Chatzis, O., Nasioudis, D., Boely Janke, E., Doco Lecompte, T., Garzoni, C., Berger, C., Cussini, A., Boggian, K., Khanna, N., et al. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12898 · Cited by 108
McCarty, T. P., Baddley, J. W., Walsh, T. J., Alexander, B. D., Kontoyiannis, D. P., Perl, T. M., Walker, R. C., Patterson, T. F., Schuster, M. G., Lyon, G. M., et al. (2015) · Medical Mycology · doi:10.1093/mmy/myv018 · Cited by 108
Self-citationGarcía‐Vidal, C., Barba, P., Arnán, M., Moreno, A., Ruíz-Camps, I., Gudiol, C., Ayats, J., Ortí, G., & Carratalà, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir485 · Cited by 108
Armstrong, A. E., Rossoff, J. E., Hollemon, D., Hong, D. K., Muller, W. J., & Chaudhury, S. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27734 · Cited by 108
Antibody testing in aspergillosis—quo vadis?
Page, I. D., Richardson, M. D., & Denning, D. W. (2015) · Medical Mycology · doi:10.1093/mmy/myv020 · Cited by 112
Self-citationDesmet, S., Wijngaerden, E. V., Maertens, J. A., Verhaegen, J., Verbeken, E. V., Munter, P. D., Meersseman, W., Meensel, B. V., Eldere, J. V., & Lagrou, K. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01756-09 · Cited by 108
Self-citationBreakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole
Rausch, C. R., DiPippo, A. J., Bose, P., & Kontoyiannis, D. P. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy406 · Cited by 107
High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients
Führen, J., Voskuil, W. S., Boel, C. H. E., Haas, P., Hagen, F., Meis, J. F. G. M., & Kusters, J. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv177 · Cited by 107
The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges
Tiew, P. Y., Aogáin, M. M., Ali, N. A. B. M., Thng, K. X., Goh, K., Lau, K. J. X., & Chotirmall, S. H. (2020) · Mycopathologia · doi:10.1007/s11046-019-00413-z · Cited by 113
Li, C., Wu, X., Feng, X., He, Y., Liu, H., Pei, F., Liao, J., He, L. Y., Shi, L., Li, N., et al. (2012) · Blood · doi:10.1182/blood-2012-03-417998 · Cited by 107
Detection of 2-Pentylfuran in the breath of patients withAspergillus fumigatus
Chambers, S. T., Syhre, M., Murdoch, D. R., McCartin, F., & Epton, M. (2009) · Medical Mycology · doi:10.1080/13693780802475212 · Cited by 107
Sun, Y., Meng, F., Han, M., Zhang, X., Yu, L., Huang, H., Wu, D., Ren, H., Wang, C., Shen, Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.018 · Cited by 107
Styczyński, J., Czyźewski, K., Wysocki, M. S., Gryniewicz–Kwiatkowska, O., Gietka, A., Salamonowicz, M., Hutnik, L. M., Zając‐Spychała, O., Zaucha‐Prażmo, A., Chelmecka-Wiktorczyk, L., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.017 · Cited by 106
Baker, A. W., Maziarz, E. K., Arnold, C., Johnson, M. D., Workman, A. D., Reynolds, J. M., Perfect, J. R., & Alexander, B. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz156 · Cited by 106
Self-citationChiche, E., Rahmé, R., Bertoli, S., Dumas, P., Micol, J., Hicheri, Y., Pasquier, F., Péterlin, P., Chevallier, P., Thomas, X., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003159 · Cited by 106
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications
Sherif, R. D., & Segal, B. H. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328337d6de · Cited by 108
Self-citationSun, H., Alexander, B. D., Huprikar, S. S., Forrest, G. N., Bruno, D., Lyon, G. M., WRAY, D. W., Johnson, L. B., Sifri, C. D., Razonable, R. R., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu711 · Cited by 106
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 109
Wang, H., Xiao, M., Chen, S. C.-A., Kong, F., Sun, Z., Liao, K., Lü, J., Shao, H., Yan, Y., Fan, H. S., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01130-12 · Cited by 105
PTX3 Polymorphisms and Invasive Mold Infections After Solid Organ Transplant: Figure 1.
Wójtowicz, A., Lecompte, T., Bibert, S., Manuel, O., Rüeger, S., Berger, C., Boggian, K., Cusini, A., Garzoni, C., Hirsch, H. H., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ386 · Cited by 105
Boch, T., Spieß, B., Cornely, O. A., Vehreschild, J. J., Rath, P., Steinmann, J., Heinz, W., Hahn, J. R., Krause, S. W., Kiehl, M. G., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.06.021 · Cited by 105
Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
Mercier, T., Guldentops, E., Lagrou, K., & Maertens, J. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00661 · Cited by 105
Self-citationFontana, L., Perlin, D. S., Zhao, Y., Noble, B. N., Lewis, J. S., Strasfeld, L. M., & Hakki, M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz282 · Cited by 105
Fisher, B. T., Zaoutis, T. E., Dvorak, C. C., Nieder, M. L., Zerr, D. M., Wingard, J. R., Callahan, C. A., Villaluna, D., Chen, L., Dang, H. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.15702 · Cited by 105
Self-citationEpidemiology and Outcome of Invasive Fungal Diseases in Patients With Chronic Granulomatous Disease
Beauté, J., Obenga, G., Mignot, L. L., Mahlaoui, N., Bougnoux, M., Mouy, R., Gougerot‐Pocidalo, M., Barlogis, V., Suárez, F., Lanternier, F., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181f13b23 · Cited by 105
Self-citationOsteomyelitis caused by Aspergillus species: a review of 310 reported cases
Gabrielli, E., Fothergill, A. W., Brescini, L., Sutton, D. A., Marchionni, E., Orsetti, E., Staffolani, S., Castelli, P., Gesuita, R., & Barchiesi, F. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12389 · Cited by 105
Carvalho, A., Cunha, C., Carotti, A., Aloisi, T., Guarrera, O., Di Ianni, M., Falzetti, F., Bistoni, F., Aversa, F., Pitzurra, L., et al. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.06.004 · Cited by 104
Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases
Pan, B., Chen, M., Pan, W., & Liao, W. (2012) · Mycoses · doi:10.1111/myc.12029 · Cited by 104
Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Lebeaux, D., Lanternier, F., Elie, C., Suárez, F., Buzyn, A., Viard, J., Bougnoux, M., Lecuit, M., Jullien, V., & Lortholary, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00939-09 · Cited by 104
Self-citationMikulska, M., Furfaro, E., Bono, V. D., Raiola, A. M., Ratto, S., Bacigalupo, A. P., & Viscoli, C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks111 · Cited by 104
Self-citationImbert, S., Gauthier, L., Joly, I., Brossas, J., Uzunov, M., Touafek, F., Brun, S., Mazier, D., Datry, A., Gay, F., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.027 · Cited by 104
Perkhofer, S., Lass‐Flörl, C., Hell, M., Russ, G., Krause, R., Hönigl, M., Geltner, C., Auberger, J., GASTL, G. A., Mitterbauer, M., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.010 · Cited by 104
Hahn‐Ast, C., Glasmacher, A. G., Mückter, S., Schmitz, A., Kraemer, A., Marklein, G., Brossart, P., & von Lilienfeld‐Toal, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp507 · Cited by 104
Bretagne, S., Sitbon, K., Desnos‐Ollivier, M., Garcia‐Hermoso, D., Letscher‐Bru, V., Cassaing, S., Millon, L., Morio, F., Gangneux, J., Hasseine, L., et al. (2022) · mBio · doi:10.1128/mbio.00920-22 · Cited by 103
Self-citationIncreased Incidence of Invasive Fusariosis with Cutaneous Portal of Entry, Brazil
Nucci, M., Varon, A. G., Garnica, M. M., Akiti, T., Barreiros, G., Trope, B. M., & Nouér, S. A. (2013) · Emerging infectious diseases · doi:10.3201/eid1910.120847 · Cited by 103
An Update on Pulmonary Complications of Hematopoietic Stem Cell Transplantation
Amy, K., Soubani, A. O., White, A. C., & Miller, K. B. (2013) · CHEST Journal · doi:10.1378/chest.12-1708 · Cited by 103
Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis
Koo, S., Porter, J., Baden, L. R., & Marty, F. M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02281-09 · Cited by 103
On the behalf of the ECMM Working Group, Tortorano, A. M., Prigitano, A., Esposto, M. C., Arsić-Arsenijević, V. S., Kolarović, J., Ivanović, D., Paripović, L., Klingspor, L., Nordøy, I., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2111-1 · Cited by 102
Eigl, S., Hoenigl, M., Spieß, B., Heldt, S., Prattes, J., Neumeister, P., Wölfler, A., Rabensteiner, J., Prüller, F., Krause, R., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myw102 · Cited by 102
Marr, K. A., Sun, Y., Spec, A., Lu, N., Panackal, A. A., Bennett, J. E., Pappas, P. G., Ostrander, D. B., Datta, K., Zhang, S. X., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz193 · Cited by 102
Self-citationSchwartz, I. S., Friedman, D. Z. P., Zapernick, L., Dingle, T. C., Lee, N. L. S., Sligl, W., Zelyas, N. J., & Smith, S. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa007 · Cited by 102
Husain, S., Clancy, C. J., Nguyen, M. H., Swartzentruber, S., Leather, H. L., LeMonte, A. M., Durkin, M., Knox, K. S., Hage, C. A., Bentsen, C. G., et al. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00226-08 · Cited by 102
Self-citationRybak, J. M., Marx, K. R., Nishimoto, A. T., & Rogers, P. D. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1652 · Cited by 101
Mellinghoff, S. C., Hoenigl, M., Koehler, P. A., Kumar, A., Lagrou, K., Lass‐Flörl, C., Meis, J. F. G. M., Menon, V. P., Rautemaa‐Richardson, R., & Cornely, O. A. (2018) · Mycoses · doi:10.1111/myc.12746 · Cited by 105
Cesaro, S., Tridello, G., Castagnola, E., Calore, E., Carraro, F., Mariotti, I., Colombini, A., Perruccio, K., Decembrino, N., Russo, G. M., et al. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12910 · Cited by 100
Ruhnke, M., Behre, G., Buchheidt, D., Christopeit, M., Hamprecht, A. G., Heinz, W., Heußel, C. P., Horger, M., Kurzai, O., Karthaus, M., et al. (2018) · Mycoses · doi:10.1111/myc.12838 · Cited by 100
Self-citationA retrospective series of gut aspergillosis in haematology patients
Kazan, E., Maertens, J., Herbrecht, R., Weisser, M., Gachot, B., Vekhoff, A., Caillot, D., Raffoux, E., Fagot, T., Reman, O., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03310.x · Cited by 99
Self-citationThe role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside
Seyedmousavi, S., Mouton, J. W., Melchers, W. J. G., Brüggemann, R. J. M., & Verweij, P. E. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.06.001 · Cited by 99
Graeff, L. D., Seidel, D., Vehreschild, M. J. G. T., Hamprecht, A. G., Kindo, A. J., Ráčil, Z., Demeter, J., de Hoog, S., Aurbach, U., Ziegler, M., et al. (2017) · Mycoses · doi:10.1111/myc.12595 · Cited by 99
Fan, X., Xiao, M., Zhang, D., Huang, J.-J., Wang, H., Hou, X., Zhang, L., Kong, F., Chen, S. C.-A., Tong, Z., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.007 · Cited by 99
Bays, D. J., & Thompson, G. R. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.010 · Cited by 99
Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing
Nucci, M., Carlesse, F. A. D. M. C., Cappellano, P., Varon, A. G., Seber, A., Garnica, M. M., Nouér, S. A., & Colombo, A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087784 · Cited by 99
Schwartz, S., Reisman, A. L., & Troke, P. F. (2011) · Infection · doi:10.1007/s15010-011-0108-6 · Cited by 99
Enteral versus parenteral nutritional support in allogeneic haematopoietic stem-cell transplantation
Guièze, R., Lemal, R., Cabrespine, A., Hermet, É., Tournilhac, O., Combal, C., Bay, J., & Bouteloup, C. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.07.012 · Cited by 98
Antifungal therapy in invasive fungal infections
Chen, S. C. ‐., Playford, E. G., & Sorrell, T. C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.002 · Cited by 98
Self-citationPulmonary Mucormycosis: Radiologic Features at Presentation and Over Time
Hammer, M. M., Madan, R., & Hatabu, H. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18792 · Cited by 98
Cuenca‐Estrella, M., Meije, Y., Díaz‐Pedroche, C., Gómez‐López, A., Buitrago, M. J., Bernal‐Martínez, L., Grande, C., Juan, R. S., Lizasoaín, M., Rodrı́guez-Tudela, J. L., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01716-08 · Cited by 98
Wang, T., Chen, S., Sun, J., Cai, J., Cheng, X., Dong, H., Wang, X., Xing, J., Dong, W., Yao, H., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt369 · Cited by 98
The occurrence of histoplasmosis in Brazil: A systematic review
Almeida, M. D. A., Almeida‐Silva, F., Guimaraes, A. J., Almeida‐Paes, R., & Zancopé‐Oliveira, R. M. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.07.009 · Cited by 97
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets
Kimura, M., Kothari, S. P., Gohir, W., Camargo, J. F., & Husain, S. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-23 · Cited by 100
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival
Vironneau, P., Kania, R. E., Herman, P., Morizot, G., Garcia‐Hermoso, D., Lortholary, O., Lanternier, F., Elie, C., & French Mycosis Study Group (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12408 · Cited by 97
Self-citationPagano, L., Valentini, C. G., Posteraro, B., Girmenia, C., Ossi, C. M., Pan, A. S., Candoni, A., Nosari, A., Riva, M., Cattaneo, C. M., et al. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.322 · Cited by 97
Garnacho‐Montero, J., Olaechea, P., Álvarez-Lerma, F., Álvarez-Rocha, L., Blanquer, J., Galván, B., Rodríguez, A. H., Zaragoza, R., Aguado, J. M., Mensa, J., et al. (2013) · PubMed · Cited by 97
Kyrmizi, I., Ferreira, H., Carvalho, A., Figueroa, J. A. L., Zarmpas, P., Cunha, C., Akoumianaki, T., Stylianou, K., Deepe, G. S., Samonis, G., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0167-x · Cited by 96
León, C., Ruiz‐Santana, S., Saavedra, P., Castro, C., Úbeda, A., Loza, A., Martín‐Mazuelos, E., Blanco, A., Jerez, V., Ballús, J., et al. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2616-y · Cited by 96
Blyth, C. C., Middleton, P. G., Harun, A. B., Sorrell, T. C., Meyer, W., & Chen, S. C.-A. (2010) · Medical Mycology · doi:10.3109/13693786.2010.500627 · Cited by 96
Self-citationvan Paassen, J., Russcher, A., Wingerden, A. W. M. I. V.-V., Verweij, P. E., & Kuijper, E. J. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.30.30300 · Cited by 96
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia
Zhou, H., Yao, Y., Zhu, B., Ren, D., Yang, Q., Fu, Y., Yu, Y., & Zhou, J. (2019) · Medicine · doi:10.1097/md.0000000000014937 · Cited by 96
Invasive aspergillosis in patients with liver disease
Falcone, M., Massetti, A. P., Russo, A., Vullo, V., & Venditti, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.535030 · Cited by 100
Snelders, E., Melchers, W. J. G., & Verweij, P. E. (2011) · Future Microbiology · doi:10.2217/fmb.11.4 · Cited by 98
van der Velden, W. J. F. M., Herbers, A. H. E., Feuth, T. B., Schaap, N. P., Donnelly, J. P., & Blijlevens, N. M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015156 · Cited by 96
Self-citationKim, S., Kwon, J., Choi, S., Lee, D., Park, S. H., Choi, J., Yoo, J., Cho, B., Eom, K., Kim, Y., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1631-y · Cited by 95
Hauser, P. M., Billé, J., Lass‐Flörl, C., Geltner, C., Feldmesser, M., Levi, M. H., Patel, H., Muggia, V. A., Alexander, B. D., Hughes, M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-10 · Cited by 95
Self-citation
Metadata
- Authors
- De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., Denning, D. W., Patterson, T. F., Maschmeyer, G., Bille, J., Dismukes, W. E., Herbrecht, R., Hope, W. W., Kibbler, C. C., Kullberg, B. J., Marr, K. A., Muñoz, P., Odds, F. C., Perfect, J. R., Restrepo, A., Ruhnke, M., Segal, B. H., Sobel, J. D., Sorrell, T. C., Viscoli, C., Wingard, J. R., Zaoutis, T., & Bennett, J. E.
- Affiliations
- Radboud University Medical Center (NL)
- Corresponding author
- Donnelly, J. Peter
- ORCID
- Walsh, Thomas J.
- Donnelly, J. Peter
- Stevens, David A.
- Edwards, John E.
- Calandra, Thierry
- Pappas, Peter G.
- Maertens, Johan
- Lortholary, Olivier
- Denning, David W.
- Patterson, Thomas F.
- Maschmeyer, Georg
- Herbrecht, Raoul
- Hope, William W.
- Kullberg, Bart Jan
- Marr, Kieren A.
- Perfect, John R.
- Ruhnke, Markus
- Segal, Brahm H.
- Sobel, Jack D.
- Sorrell, Tania C.
- Wingard, John R.
- Zaoutis, Theoklis
- Bennett, John E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-15
- Volume
- 46
- Issue
- 12
- Pages
- 1813-1821
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC2671227
- OpenAlex
- W2166734004
- Cited by
- 4,917
- References
- 28
- Citations by year
- 2026: 85 · 2025: 146 · 2024: 169 · 2023: 172 · 2022: 203 · 2021: 280 · 2020: 362 · 2019: 424 · 2018: 383 · 2017: 354 · 2016: 345 · 2015: 376 · 2014: 363 · 2013: 299 · 2012: 279
- FWCI
- 140.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion)
- IRIS (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Amgen
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Children's Hospital of Philadelphia
- Wayne State University
- University of Pennsylvania
- Wellcome Trust
- Valeant Pharmaceuticals International
- European Commission
- University of Aberdeen
- European Organisation for Research and Treatment of Cancer
- Astellas Pharma
- Centre Hospitalier Universitaire Vaudois
- Basilea Pharmaceutica
- Italfarmaco
- National Institutes of Health
- University at Buffalo
- Medical School, University of Michigan
- University of Texas Health Science Center at San Antonio
- Medical Research Council
- National Health and Medical Research Council
- National Institute of Allergy and Infectious Diseases (Z01AI000654)
- Janssen Pharmaceuticals
- UCB Pharma
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- invasive fungal infections, diagnostic definitions, immunocompromised patients, clinical trial endpoints, fungal epidemiology
- MeSH terms
- Humans, Mycoses, Terminology as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review